Unlocking pathology archives for molecular genetic studies:: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization

被引:71
作者
Lambros, MBK
Simpson, PT
Jones, C
Natrajan, R
Westbury, C
Steele, D
Savage, K
Mackay, A
Schmitt, FC
Ashworth, A
Reis, JS
机构
[1] Inst Canc Res, Breakthrough Breast Canc Res, London SW3 6JB, England
[2] Univ Queensland, Queensland Inst Med Res, Mayne Med Sch, Brisbane, Qld, Australia
[3] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia
[4] Inst Canc Res, Sect Paediat Oncol, Sutton, Surrey, England
[5] Inst Mol Pathol & Immunol, IPATIMUP, Oporto, Portugal
[6] Univ Porto, Fac Med, P-4100 Oporto, Portugal
关键词
chromogenic in situ hybridization; fluorescent in situ hybridization; comparative genomic hybridization; molecular pathology; protocol;
D O I
10.1038/labinvest.3700390
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Chromogenic (CISH) and fluorescent ( FISH) in situ hybridization have emerged as reliable techniques to identify amplifications and chromosomal translocations. CISH provides a spatial distribution of gene copy number changes in tumour tissue and allows a direct correlation between copy number changes and the morphological features of neoplastic cells. However, the limited number of commercially available gene probes has hindered the use of this technique. We have devised a protocol to generate probes for CISH that can be applied to formalin-fixed, paraffin-embedded tissue sections (FFPETS). Bacterial artificial chromosomes ( BACs) containing fragments of human DNA which map to specific genomic regions of interest are amplified with phi 29 polymerase and random primer labelled with biotin. The genomic location of these can be readily confirmed by BAC end pair sequencing and FISH mapping on normal lymphocyte metaphase spreads. To demonstrate the reliability of the probes generated with this protocol, four strategies were employed: (i) probes mapping to cyclin D1 (CCND1) were generated and their performance was compared with that of a commercially available probe for the same gene in a series of 10 FFPETS of breast cancer samples of which five harboured CCND1 amplification; (ii) probes targeting cyclin-dependent kinase 4 were used to validate an amplification identified by microarray-based comparative genomic hybridization (aCGH) in a pleomorphic adenoma; (iii) probes targeting fibroblast growth factor receptor 1 and CCND1 were used to validate amplifications mapping to these regions, as defined by aCGH, in an invasive lobular breast carcinoma with FISH and CISH; and (iv) gene-specific probes for ETV6 and NTRK3 were used to demonstrate the presence of t(12; 15)(p12; q25) translocation in a case of breast secretory carcinoma with dual colour FISH. In summary, this protocol enables the generation of probes mapping to any gene of interest that can be applied to FFPETS, allowing correlation of morphological features with gene copy number.
引用
收藏
页码:398 / 408
页数:11
相关论文
共 30 条
[11]   Patterns of chromosomal alterations in breast ductal carcinoma in situ [J].
Hwang, ES ;
DeVries, S ;
Chew, KL ;
Moore, DH ;
Kerlikowske, K ;
Thor, A ;
Ljung, BM ;
Waldman, FM .
CLINICAL CANCER RESEARCH, 2004, 10 (15) :5160-5167
[12]   Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma [J].
Hwang, ES ;
Nyante, SJ ;
Chen, YY ;
Moore, D ;
DeVries, S ;
Korkola, JE ;
Esserman, LJ ;
Waldman, FM .
CANCER, 2004, 100 (12) :2562-2572
[13]   Interlaboratory comparison of HER-2 oncogene amplification as detected by chromogenic and fluorescence in situ hybridization [J].
Isola, J ;
Tanner, M ;
Forsyth, A ;
Cooke, TG ;
Watters, AD ;
Bartlett, JMS .
CLINICAL CANCER RESEARCH, 2004, 10 (14) :4793-4798
[14]   Whole genome analysis of genetic alterations in small DNA samples using hyperbranched strand displacement amplification and array-CGH [J].
Lage, JM ;
Leamon, JH ;
Pejovic, T ;
Hamann, S ;
Lacey, M ;
Dillon, D ;
Segraves, R ;
Vossbrinck, B ;
González, A ;
Pinkel, D ;
Albertson, DG ;
Costa, J ;
Lizardi, PM .
GENOME RESEARCH, 2003, 13 (02) :294-307
[15]   HER2 positivity in breast carcinoma: A comparison of chromogenic in situ hybridization with fluorescence in situ hybridization in tissue microarrays, with targeted evaluation of intratumoral heterogeneity by in situ hybridization [J].
Loring, P ;
Cummins, R ;
O'Grady, A ;
Kay, EW .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2005, 13 (02) :194-200
[16]   A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma [J].
Makretsov, N ;
He, M ;
Hayes, M ;
Chia, S ;
Horsman, DE ;
Sorensen, PHB ;
Huntsman, DG .
GENES CHROMOSOMES & CANCER, 2004, 40 (02) :152-157
[17]  
Pandis N, 1998, GENE CHROMOSOME CANC, V22, P122, DOI 10.1002/(SICI)1098-2264(199806)22:2<122::AID-GCC6>3.0.CO
[18]  
2-Z
[19]   Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors [J].
Paris, PL ;
Andaya, A ;
Fridlyand, J ;
Jain, AN ;
Weinberg, V ;
Kowbel, D ;
Brebner, JH ;
Simko, J ;
Watson, JEV ;
Volik, S ;
Albertson, DG ;
Pinkel, D ;
Alers, JC ;
van der Kwast, TH ;
Vissers, KJ ;
Schroder, FH ;
Wildhagen, MF ;
Febbo, PG ;
Chinnaiyan, AM ;
Pienta, KJ ;
Carroll, PR ;
Rubin, MA ;
Collins, C ;
van Dekken, H .
HUMAN MOLECULAR GENETICS, 2004, 13 (13) :1303-1313
[20]   Array comparative genomic hybridization and its applications in cancer [J].
Pinkel, D ;
Albertson, DG .
NATURE GENETICS, 2005, 37 (Suppl 6) :S11-S17